Reboxetine

Guest Blog: The antidepressant reboxetine: A headdesk moment in science ❋ Matthew Herper (2011)

In short-term acute therapy reboxetine does not alleviate symptoms of depression as well as drugs in the SSRI drug class. ❋ Unknown (2009)

Dr. Cipriani said he would not prescribe reboxetine as a first-line treatment in his patients. ❋ Unknown (2009)

Dr. Cipriani also noted that reboxetine is the only norepinephrine reuptake inhibitor assessed in their review. ❋ Unknown (2009)

Schatzberg A (2000) Clinical efficacy of reboxetine in major depression. ❋ Unknown (2009)

One low dose of the antidepressant reboxetine increased depressed patients 'responses to positive facial expressions and personality characteristics, while their mood ratings remained ❋ Unknown (2009)

Sertraline was found to be more effective than duloxetine by 30\%, fluvoxamine (27\%), fluoxetine (25\%), paroxetine (25\%), and reboxetine (85\%). ❋ Unknown (2009)

The IQWiG claims the process was "greatly hindered" by Pfizer, which took a "long time" to make available trial data on reboxetine. ❋ Unknown (2009)

The summary of results from published and non-published trials does not provide proof of benefit of reboxetine, whereas the data from the published trials appear to suggest a benefit. ❋ Unknown (2009)

Note that reboxetine was the least efficacious and least-tolerated drug in the meta-analysis. ❋ Unknown (2009)

The institute's move follows a disagreement with Pfizer concerning unpublished study data about the company's antidepressant reboxetine. ❋ Unknown (2009)

Zoloft, Lexapro the Best of Newer Antidepressants paroxetine (Paxil), reboxetine (Edronax / Vestra), sertraline, and venlafaxine (Effexor). ❋ Unknown (2009)

The final evaluation of reboxetine and mirtazapine was only possible after manufacturers disclosed data that had previously been concealed. ❋ Unknown (2009)

discontinuation of late-stage development for SS-reboxetine (SNRI for fibromyalgia), ❋ Unknown (2010)